Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical 2-Deoxy-D-ribose Hydrogel vs Minoxidil in Androgenetic Alopecia
NCT07502976Recruiting
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Jan 2026
- Primary completion
- Oct 2026
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of 2-deoxy-D-ribose in androgenetic alopecia (AGA) (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoints: Change in Terminal Hair Density at 12 weeks, Change in Total Hair Density at 12 weeks and 1 more. Started Jan 2026; status: recruiting.
02
Drugs
2-deoxy-D-ribose
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT07502976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07502976.